Suppr超能文献

大流行病悲伤量表:用于筛查因 COVID-19 丧失而导致的功能失调性悲伤的工具。

Pandemic Grief Scale: A screening tool for dysfunctional grief due to a COVID-19 loss.

机构信息

Christopher Newport University, Newport News, Virginia, USA.

University of Memphis and Portland Institute for Loss and Transition, Portland, Oregon, USA.

出版信息

Death Stud. 2022;46(1):14-24. doi: 10.1080/07481187.2020.1853885. Epub 2020 Dec 21.

Abstract

Millions of people are grieving the loss of someone who died of COVID-19. However, there have been no screening tools developed to identify individuals who may be suffering from dysfunctional grief during the pandemic. Therefore, the objective of this study was to develop and evaluate the properties of the Pandemic Grief Scale (PGS), which is a brief mental health screener to identify probable cases of dysfunctional grief associated with a COVID-19 death. This 5-item scale, which was based on 831 adults who lost someone to COVID-19, demonstrated solid reliability (αs = 0.86), factorial validity (PCA and CFA support), and construct validity with strong correlations with suicidal ideation and substance use coping. The PGS measures COVID-19 grief equivalently across demographic groups, and discriminates well between persons with and without dysfunctional grief using an optimized cut score of ≥ 7 (87% sensitivity and 71% specificity). An alarming 66% of the sample scored in the clinical range. The PGS also demonstrates incremental validity by explaining 18% additional variance in functional impairment due to a COVID-19 loss beyond measures of depression and generalized anxiety. These results support the PGS as an efficient and valid screening tool for clinical research and practice during a pandemic.

摘要

数百万人因 COVID-19 逝者而悲痛。然而,目前尚无筛选工具来确定在大流行期间可能患有功能失调性悲伤的个体。因此,本研究的目的是开发和评估大流行病悲伤量表(PGS)的特性,该量表是一种简短的心理健康筛查工具,用于识别与 COVID-19 死亡相关的可能功能失调性悲伤病例。该 5 项量表基于 831 名因 COVID-19 失去亲人的成年人,具有可靠的信度(αs = 0.86)、因子有效性(PCA 和 CFA 支持)和结构有效性,与自杀意念和物质使用应对的相关性较强。PGS 在人口统计学群体中平等地衡量 COVID-19 悲伤,并且使用≥7 的优化截断分数(87%的敏感性和 71%的特异性)很好地区分了有无功能失调性悲伤的人群。令人震惊的是,样本中有 66%的人得分处于临床范围。PGS 还通过解释 COVID-19 损失导致的功能障碍中抑郁和广泛性焦虑以外的措施之外的 18%的额外方差,显示出增量有效性。这些结果支持 PGS 作为大流行期间临床研究和实践的有效和有效筛选工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验